Toxins
2004 – Dow Chemical Company
Whereas
Concerns about chemical hazards
are growing. Increased monitoring is demonstrating widespread exposure from
current and past practices. In the opinion of the proponents, related policy
proposals and litigation will also grow, with implications for Dow.
New technologies of analysis
make it possible to detect chemicals such as dioxin and pesticides in the
bodies of people, even at low levels, and to identify trends in chemical
exposures. Among these are compounds found in Dow products, such as Dursban.
The testing may aid the correlation of exposure to disease, and liability suits
against chemical producers.
Dow's Midland, Michigan
manufacturing facility releases dioxin to air, land and water. The surrounding
city and watershed are contaminated with dioxin, with levels detected in the
floodplain downriver as high as 80 times the state's residential cleanup
standard. A state advisory has warned that exposure to the contaminated soil
could pose a health hazard. A class action lawsuit on behalf of as many as 2000
residents asserts property damages and seeks medical monitoring.
Agent Orange, a Vietnam era
pesticide, was contaminated with dioxins. US and Vietnamese veterans and their
families are demanding compensation from Dow. A 2003 US Supreme Court decision
may allow thousands of new US veterans' suits to proceed.
Emerging public policies may
require changes in production and use of certain Dow product lines. For
example, the European Union proposes requiring manufacturers that sell
chemicals in Europe to provide data on hazards and uses, and would require
special approval of certain "very high concern" chemicals, including
some persistent and bioaccumulative toxics, carcinogens, mutagens and
reproductive toxins. The Stockholm Treaty on Persistent Organic Pollutants and
the Great Lakes Water Quality Agreement both encourage elimination of
persistent toxic chemical products and precursors.
In the opinion of the
proponents, management's sustainability report and SEC filings obscure rather
than clarify some of the most important policy issues confronting Dow, because
they leave gaps in disclosure, specifically:
·
How public policies may impact the company's product
lines, including the Stockholm POPs treaty, Great Lakes Water Quality Agreement
and the proposed European REACH program.
·
The list of Dow Chemical products anticipated to
require specific authorization or be restricted under the proposed European
"REACH" program.
·
A company plan and timeline for phase-out of each
product involving a persistent, bioaccumulative chemical or byproduct, or an
explanation of why alternatives cannot be substituted, explaining how the
company will respond to rising regulatory, competitive and public pressure.
·
A listing of the reasonable range of projected costs of
remediation or liability anticipated for (a) Midland, Michigan, (b) Agent
Orange, and (c) each of the other potentially material toxic sites and issues
facing the company.
RESOLVED: Shareholders request
that the Board publish by October 2004, at reasonable cost and excluding
confidential information, a report filling the gaps in Dow Chemical
transparency discussed above.
Sponsors:
Lead: Trillium Asset Management, Ms. Shelley
Alpern